Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Glen Rock, NJ
SEC filing record 1 source field available
Fiscal year end
31 December
RespireRx Pharmaceuticals Inc. has filed 926 SEC EDGAR filings since 30 Oct 1995

SEC filing history

Showing 1-25 of 517 matching filings.

Per page
25
Current page
1
REVOKED File 001-16467

REVOKED filing

Filing date
14 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-K File 001-16467

NT 10-K filing

Filing date
01 Apr 2024
Reporting date
31 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-16467

10-Q filing

Filing date
17 Nov 2023
Reporting date
30 Sep 2023
Next action
Verify source filing
NT 10-Q File 001-16467

NT 10-Q filing

Filing date
14 Nov 2023
Reporting date
30 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-16467

10-Q filing

Filing date
21 Aug 2023
Reporting date
30 Jun 2023
Next action
Verify source filing
NT 10-Q File 001-16467

NT 10-Q filing

Filing date
14 Aug 2023
Reporting date
30 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-16467

10-Q filing

Filing date
22 May 2023
Reporting date
31 Mar 2023
Next action
Verify source filing
NT 10-Q File 001-16467

NT 10-Q filing

Filing date
15 May 2023
Reporting date
31 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-16467

10-K filing

Filing date
17 Apr 2023
Reporting date
31 Dec 2022
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .